Pharming « Terug naar discussie overzicht

Pharming woensdag 18 juni 2014. De dag dat er weer 100 miljoen aandelen erbij kwamen!

464 Posts, Pagina: « 1 2 3 4 5 6 ... 16 17 18 19 20 21 22 23 24 » | Laatste
dader
0
Met 1-1 rust moet we heeeeeel blij zijn.tot nu toe is een gelijkspel het maximaal haalbare
Wat een klote wedstrijd ,waar zijn de bejubelde achterhoed van 010 en spits PERSIE
voda
0
HOT NEWS: Pharming aandeelhouders stemmen in met alle AVA-voorstellen
(MORE TO FOLLOW) Dow Jones Newswires

[verwijderd]
0
quote:

voda schreef op 18 juni 2014 19:04:

HOT NEWS: Pharming aandeelhouders stemmen in met alle AVA-voorstellen
(MORE TO FOLLOW) Dow Jones Newswires


Zoals verwacht toch...
JeffW
0
quote:

voda schreef op 18 juni 2014 19:04:

HOT NEWS: Pharming aandeelhouders stemmen in met alle AVA-voorstellen
(MORE TO FOLLOW) Dow Jones Newswires


Is er ergens een korte samenvatting van de belangrijkste voorstellen? (buiten de 100K aandelen).

[verwijderd]
0
voda
0
Pharming Reports On Annual General Meeting Of Shareholders

Leiden, the Netherlands, 18 June 2014. Biotech company Pharming Group NV (“Pharming” or “the Company”) NYSE Euronext: PHARM) announced that at its Annual General Meeting (AGM) of shareholders, held today, all proposals were approved.

The presentation slides of today’s AGM are available on the Company’s website.

About Pharming Group NV

Pharming Group NV is developing innovative products for the treatment of unmet medical needs. RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of angioedema attacks in patients with HAE in all 27 EU countries plus Norway, Iceland and Liechtenstein, and is distributed in the EU by Swedish Orphan Biovitrum. RUCONEST® is partnered with Salix Pharmaceuticals Inc. (NASDAQ: SLXP) in North America and a Biologics License Application (BLA) for RUCONEST® is under review by the U.S. Food and Drug Administration. The product is also being evaluated for various follow-on indications. Pharming has a unique GMP compliant, validated platform for the production of recombinant human proteins that has proven capable of producing industrial volumes of high quality recombinant human protein in a more economical way compared to current cell based technologies. In July 2013, the Platform was partnered with Shanghai Institute for Pharmaceutical Industry (SIPI), a Sinopharm Company, for joint global development of new products. Pre- clinical development and manufacturing will take place at SIPI and are funded by SIPI. Pharming and SIPI initially plan to utilise this platform for the development of rhFVIII for the treatment of Haemophilia A. Additional information is available on the Pharming website, www.pharming.com. Additional information is available on the Pharming website, www.pharming.com.

This press release contains forward looking statements that involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the results, performance or achievements expressed or implied by these forward looking statements.

Contact:
Sijmen de Vries, CEO: T: +31 71 524 7400
FTI Consulting Julia Phillips/ John Dineen, T: +44 (0)207 269 7193

dader
0
quote:

voda schreef op 18 juni 2014 19:04:

HOT NEWS: Pharming aandeelhouders stemmen in met alle AVA-voorstellen
(MORE TO FOLLOW) Dow Jones Newswires


[verwijderd]
0
[verwijderd]
0
€1 heeft gelijk. Als Spanje vanavond wint van Chili (wat heel logisch zal zijn 3-0) dan mag Nederland niet verliezen van Chili... Dat wordt lastig..
[verwijderd]
0
dader
0
quote:

JaneJungle schreef op 18 juni 2014 19:11:

Nou keeper moet Ajax redden...
Anders gedaan.. Niet eens tweede ronde..

2-2 phoooooeeeooooe
464 Posts, Pagina: « 1 2 3 4 5 6 ... 16 17 18 19 20 21 22 23 24 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 4 apr 2025 10:39
Koers 0,714
Verschil -0,003 (-0,42%)
Hoog 0,726
Laag 0,710
Volume 1.565.447
Volume gemiddeld 5.556.890
Volume gisteren 5.962.202